Involvement of the pharmaceutical and biotechnology industry is fundamental in achieving the mission of the Alliance. This sector can contribute knowledge and resources needed to drive novel drug discovery and development in progressive MS.

Industry participates in the work of the Alliance through the Industry Forum, the venue for industry members to provide advice and recommendations to the Alliance Scientific Steering Committee and contribute financial support towards the ongoing research initiatives of the Alliance.

Co-Chairs

Marco Salvetti, Director, Neurology Unit, Sant’Andrea University Hospital, Rome; Director, PhD Programme on Clinical and Experimental Neurosciences and Psychiatry, Sapienza University of Rome, (IT)

Florian von Raison, Clinical Development Head Neuroscience, Global Drug Development, Novartis, (FR)

Members

Ivan Bozin, Senior Medical Manager, Biogen, (CH)
Licinio Craveiro, Neurologist, Senior Global Medical Director, Genentech Roche, (CH)
Kate Daniels, Director, International Progressive MS Alliance, (US)
Shawna Golden, Vice President, Global Initiatives, International Progressive MS Alliance, (US)
Andrew Goldfine, Senior Clinical Development Director, GlaxoSmithKline (US)
Jerome Hanna, Senior Medical Director, Clinical Development, Biogen, (UK)
Danielle Harlow, Senior Medical Director, Global Medical Affairs, EMD Serono, (US)
Andreas Muehler, Chief Medical Officer, Immunic Therapeutics, (DE)
Ashish Pradhan, Executive Director Neuroimmunology, Disease Area Lead – Medical Affairs, Genentech, (US)
Laura Rapley, Scientific Lead, Chronic Inflammatory Diseases, GlaxoSmithKline, (UK)
Nikolaos Sfikas, Senior IIS Global Group Head, Novartis, (FR)
Sana Syed, Senior Medical Director, Clinical Lead, Sanofi, (US)
Kirk Taylor, Chief Medical Officer, Brainstorm Cell Therapeutics, (US)
Davorka Tomic, Head Global Clinical Development in MS, Merck (EMD Serono), (US)
Erik Wallström, Therapeutic Area Head, Neurology, Sanofi, (US)
Paola Zaratin, Director of Scientific Research, AISM — Italian MS Society, (IT)

 

Join Us.

Together we are stronger than progressive MS.

Join Us.